Justin Dillingham
Family Medicine · Joplin, MONPI 1003103490
Payments from drug & device makers
Across 115 payments — averaging $12.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$403
- Pfizer$166
- Amgen$141
- Lilly USA, LLC$117
- Abbott$84
- GSK$74
- plus $476 from 16 others
What the payments were for
- Food & beverage$1,461100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $403 |
| Pfizer | 14 | $166 |
| Amgen | 8 | $141 |
| Lilly USA, LLC | 9 | $117 |
| Abbott | 5 | $84 |
| GSK | 6 | $74 |
| Boehringer Ingelheim | 5 | $73 |
| AstraZeneca | 5 | $61 |
| Teva Pharmaceuticals USA, Inc. | 4 | $46 |
| Sanofi-aventis U.S. LLC | 3 | $40 |
| Merck | 3 | $40 |
| Johnson & Johnson | 3 | $40 |
| Novo Nordisk | 2 | $31 |
| Dexcom, Inc. | 2 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Novartis | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Circassia Inc. | 1 | $11 |
How this compares
$1,461 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 130 | $102,159 |
| TrulicityDulaglutide | 89 | $87,784 |
| OzempicSemaglutide | 38 | $57,759 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $42,959 |
| FarxigaDapagliflozin Propanediol | 47 | $38,895 |
| MounjaroTirzepatide | 22 | $34,764 |
| JanuviaSitagliptin Phosphate | 35 | $28,161 |
| JardianceEmpagliflozin | 22 | $27,420 |
| XareltoRivaroxaban | 26 | $23,377 |
| Repatha SureclickEvolocumab | 20 | $21,275 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 98 | $17,489 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 35 | $17,446 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $15,869 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $13,902 |
| MyrbetriqMirabegron | 21 | $13,881 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $117 | $122,548111 claims |
| PfizerEliquis | $166 | $102,159130 claims |
| Novo NordiskOzempic | $31 | $57,75938 claims |
| AstraZenecaFarxiga, Symbicort | $61 | $50,50783 claims |
| GSKTrelegy Ellipta, Arexvy | $74 | $47,65370 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $73 | $44,86557 claims |
| MerckJanuvia | $40 | $28,16135 claims |
| Johnson & JohnsonXarelto | $40 | $23,37726 claims |
| AbbVieLinzess | $403 | $10,22311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Joplin
- Luke WickeJoplin$18K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.